By putting its foot in the door at the FDA, can 23andMe reinvigorate direct-to-consumer genomics? Malorye Allison investigates.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making
Genome Medicine Open Access 29 March 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
The American College of Obstetricians and Gynecologists. Committee Opinion on Personalized Genomic Testing for Disease Risk. June, 2012. http://www.acog.org/Resources_And_Publications/Committee_Opinions/Committee_on_Genetics/Personalized_Genomic_Testing_for_Disease_Risk
Allison, M. Nat. Biotechnol. 28, 633 (2010).
Eriksson, N. PLoS Genet. 6, e1000993 (2010).
Harmon, A. Gene map becomes a luxury item. New York Times, March 4, 2008. http://www.nytimes.com/2008/03/04/health/research/04geno.html?_r=0
DeFrancesco, L. & Subbaraman, N. Nat. Biotechnol. 29, 379–380 (2011).
Roberts, N.J. et al. Sci. Transl. Med. 4, 133ra58 (2012).
Author information
Authors and Affiliations
Supplementary information
Supplementary Text and Figures
Supplementary Table 1 (PDF 32 kb)
Rights and permissions
About this article
Cite this article
Allison, M. Direct-to-consumer genomics reinvents itself. Nat Biotechnol 30, 1027–1029 (2012). https://doi.org/10.1038/nbt.2409
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2409
This article is cited by
-
Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making
Genome Medicine (2021)
-
Predictors of adverse psychological experiences surrounding genome-wide profiling for disease risk
Journal of Community Genetics (2018)
-
Falling prices and unfair competition in consumer genomics
Nature Biotechnology (2013)
-
Direct-to-Consumer Genetic Testing and Personal Genomics Services: A Review of Recent Empirical Studies
Current Genetic Medicine Reports (2013)